Researchers applied a machine learning strategy in a longitudinal analysis of clinical features linked to neurofibromatosis type 1 in pediatric patients.
Surgical treatment of intracranial meningioma (IM) should be considered even in patients over the age of 80 years.
The maker of the expensive brain cancer drug Gleostine has removed it from the Medicare drug rebate program.
The combination of nivolumab with ipilimumab is an effective treatment option for patients with advanced melanoma with asymptomatic brain metastases
Occult brain metastasis is identified in about 4 percent of patients with metastatic renal cell carcinoma (mRCC).
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.
Study researchers evaluated the incidence and risk factors for seizure development among patients with brain metastases.
The incidence of venous thromboembolism and major bleeding is high among patients with primary central nervous system lymphoma.
Findings from the study showed 44% of patients treated with berubicin experienced a statistically significant improvement in progression free survival.
Treatment disparities may explain worse outcomes for pediatric black and Hispanic brain cancer patients.